Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Warren Buffett’s Latest Filing Reveals That He is Still Fond of DaVita HealthCare Partners Inc (DVA)

Warren Buffett and Berkshire Hathaway, in a new filing with the Securities and Exchange Commission, revealed buying a significant amount of shares of DaVita HealthCare Partners Inc (NYSE:DVA). Berkshire has acquired around 1.3 million shares, raising its holding in the company to a total of almost 36.5 million shares. The stock was acquired in four transactions, and the fund spent over $76 million.

Warren Buffett

According to the latest 10-Q report of DaVita HealthCare Partners Inc (NYSE:DVA), the company has around 212.7 million shares outstanding, which shows that Buffett’s stake amasses over 17% of the company’s common stock. Earlier in November, Mr. Buffett reported another increase in his holding in DaVita, when he acquired around 3.7 million shares.

Berkshire’s ‘bulishness’ on DaVita HealthCare Partners Inc (NYSE:DVA) could be explained by its intentions to get into the company in order to gain long-term value. The fund took advantage of the relatively low stock price to increase its exposure, paying between $57.11 and $59.87 to acquire the securities. Currently, the stock of DaVita trades at over $62 per share.

At the end of November, DaVita HealthCare Partners Inc (NYSE:DVA) has provided its outlook for the next year, on the back of the final Centers for Medicare and Medicaid Services (CMS) Medicare ESRD rule for 2014. The company forecasts enterprise operating income between $1.7 and $1.9 billion for 2014, amid an operating income of $1.4 – $1.5 billion from its dialysis services business, the company said in a statement. For the first nine months of 2013, DaVita posted an adjusted operating income of $1.41 billion.

While Berkshire’s stake in the company has been one of the largest, and with the recent increases the fund just solidified its position. In addition to Mr. Buffett, another “hedgie” that has been bullish on DaVita HealthCare Partners Inc (NYSE:DVA), according to the latest 13F filings, is Stephen Mandel of Lone Pine Capital, which initiated a position in the company during the third quarter and revealed 6.3 million shares as at the end of September. The holding of Orbis Investment Management, managed by William B. Gray, amasses 5.4 million shares, boosted by over 200% during the July-September period.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!